These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35866400)

  • 1. Effects of the Topical Use of the Natural Antioxidant Alpha-Lipoic Acid on the Ocular Surface of Diabetic Patients with Dry Eye Symptoms.
    Roszkowska AM; Spinella R; Oliverio GW; Postorino EI; Signorino GA; Rusciano D; Aragona P
    Front Biosci (Landmark Ed); 2022 Jun; 27(7):202. PubMed ID: 35866400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical cyclosporine A therapy for dry eye syndrome.
    de Paiva CS; Pflugfelder SC; Ng SM; Akpek EK
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD010051. PubMed ID: 31517988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Efficacy of Carboxymethylcellulose 0.5%, Hydroxypropyl-guar Containing Polyethylene Glycol 400/Propylene Glycol, and Hydroxypropyl Methyl Cellulose 0.3% Tear Substitutes in Improving Ocular Surface Disease Index in Cases of Dry Eye.
    Maharana PK; Raghuwanshi S; Chauhan AK; Rai VG; Pattebahadur R
    Middle East Afr J Ophthalmol; 2017; 24(4):202-206. PubMed ID: 29422755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Pilot Study.
    Zhang Q; Zhang H; Qin G; Wu Y; Song Y; Yang L; Yu S; He X; Moore JE; Moutari S; Palme C; Xu L; He W; Pazo EE
    J Ocul Pharmacol Ther; 2022 Mar; 38(2):133-140. PubMed ID: 35049373
    [No Abstract]   [Full Text] [Related]  

  • 5. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Prolonged Reading on Dry Eye.
    Karakus S; Agrawal D; Hindman HB; Henrich C; Ramulu PY; Akpek EK
    Ophthalmology; 2018 Oct; 125(10):1500-1505. PubMed ID: 29705055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of the IL-33/ST2 pathway in dry eye.
    Wang S; Zhang H
    Mol Vis; 2019; 25():583-592. PubMed ID: 31673224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E; Asfuroğlu E
    Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Omega-3 Fatty Acids Dietary Supplementation on Ocular Surface and Tear Film in Diabetic Patients with Dry Eye.
    Georgakopoulos CD; Makri OE; Pagoulatos D; Vasilakis P; Peristeropoulou P; Kouli V; Eliopoulou MI; Psachoulia C
    J Am Coll Nutr; 2017 Jan; 36(1):38-43. PubMed ID: 27797641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the clinical efficacy of preserved and preservative-free hydroxypropyl methylcellulose-dextran-containing eyedrops.
    Safarzadeh M; Azizzadeh P; Akbarshahi P
    J Optom; 2017; 10(4):258-264. PubMed ID: 27989693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines.
    Choi MG; Yeo JH; Kang JW; Chun YS; Lee JK; Kim JC
    Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):331-338. PubMed ID: 30552510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discomfort symptoms reduction and ocular surface parameters recovery with Artelac Rebalance treatment in mild-moderate dry eye.
    Versura P; Profazio V; Giannaccare G; Fresina M; Campos EC
    Eur J Ophthalmol; 2013; 23(4):488-95. PubMed ID: 23539457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Taufon use in myopic contact lens wearers].
    Naumenko VV; Pogosian MA; Sergeev VP
    Vestn Oftalmol; 2014; 130(4):97-8, 100-1. PubMed ID: 25306731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease.
    Lee HS; Ji YS; Yoon KC
    Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.
    Jee D; Park SH; Kim MS; Kim EC
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5081-9. PubMed ID: 24994869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-lipoic acid restores tear production in an animal model of dry eye.
    Andrade AS; Salomon TB; Behling CS; Mahl CD; Hackenhaar FS; Putti J; Benfato MS
    Exp Eye Res; 2014 Mar; 120():1-9. PubMed ID: 24394592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry eye disease among Glaucoma patients on topical hypotensive medications, in a tertiary hospital, Ethiopia.
    Sahlu M; Giorgis AT
    BMC Ophthalmol; 2021 Mar; 21(1):155. PubMed ID: 33785013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of eye drops containing a mixture of 3% diquafosol sodium and tocopherol acetate (vitamin E) on the ocular surface of murine dry eye.
    Li L; Jin R; Li Y; Yoon HS; Yoon HJ; Yoon KC
    Cutan Ocul Toxicol; 2021 Dec; 40(4):350-358. PubMed ID: 34496685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
    Hwang HS; Sung YM; Lee WS; Kim EC
    Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trehalose/sodium hyaluronate eye drops in post-cataract ocular surface disorders.
    Cagini C; Torroni G; Mariniello M; Di Lascio G; Martone G; Balestrazzi A
    Int Ophthalmol; 2021 Sep; 41(9):3065-3071. PubMed ID: 33956256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.